Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on Antiretroviral Therapy (ART) in sub-Saharan Africa: Frequency and clinical significance
Open Access
- 1 January 2008
- journal article
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 5 (1) , 23
Abstract
A proportion of individuals who start antiretroviral therapy (ART) fail to achieve adequate CD4 cell reconstitution despite sustained viral suppression. We determined the frequency and clinical significance of suboptimal CD4 reconstitution despite viral suppression (SO-CD4) in an urban HIV research cohort in Kampala, UgandaKeywords
This publication has 30 references indexed in Scilit:
- Clinical Outcome of HIV-Infected Antiretroviral-Naive Patients With Discordant Immunologic and Virologic Responses to Highly Active Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- HIV immune reconstitution syndrome in sub-Saharan AfricaAIDS, 2008
- Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3JAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Discordant Responses to Potent Antiretroviral Treatment in Previously Naive HIV-1-Infected Adults Initiating Treatment in Resource-Constrained CountriesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Determinants of Mortality and Nondeath Losses from an Antiretroviral Treatment Service in South Africa: Implications for Program EvaluationClinical Infectious Diseases, 2006
- CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan AfricaBMC Infectious Diseases, 2006
- Persistent immune activation in HIV-1 infection is associated with progression to AIDSAIDS, 2003
- Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistanceThe Lancet, 2002
- Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral TherapyAnnals of Internal Medicine, 2000
- Discrepant responses to triple combination antiretroviral therapy in advanced HIV diseaseAIDS, 1998